Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
2.22 USD -1.77% Intraday chart for Regulus Therapeutics Inc. -5.13% +73.44%
Mar. 21 Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 21 Regulus Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Chart calendar Regulus Therapeutics Inc.

2c4d9fd396.qeuOFt7plOiU8RXDfNo3HbXaa6Dk9wBkdB8YK4zaGII.4K-8I5iK55n1n16xFu9zUYWPM-Wjvi0MIVB3YsK8QLqQ2Px0mL32gPykRA~26648ace0808300811603a4bc2510d01

Upcoming events on Regulus Therapeutics Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)

Past events on Regulus Therapeutics Inc.

2024-03-21 04:05 pm Q4 2023 Earnings Release
2024-03-12 08:30 am Business Update Call
2024-01-04 Investor Meeting After hours
2023-11-29 10:25 am Evercore ISI HealthCONx Conference
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-09-20 08:30 am RGLS8429 Phase 1b Study Results Call
2023-09-11 11:00 am H.C. Wainwright Global Investment Conference
2023-09-06 11:00 am R&D Day
2023-09-05 Wells Fargo Healthcare Conference
2023-08-09 11:30 am Canaccord Genuity Growth Conference
2023-08-08 04:05 pm Q2 2023 Earnings Release
2023-07-25 03:00 pm H.C. Wainwright Kidney Conference
2023-06-01 12:00 pm Annual General Meeting
2023-05-11 04:05 pm Q1 2023 Earnings Release
2023-03-23 04:05 pm Q4 2022 Earnings Release
2023-03-08 Chronic Kidney Disease Drug Development Summit
2023-02-16 01:00 pm SVB Securities Global Biopharma Conference
2022-11-10 05:00 pm Q3 2022 Earnings Call
2022-11-10 04:05 pm Q3 2022 Earnings Release
2022-11-03 10:00 am American Society of Nephrology Kidney Week Conference - Abstract Number: 3768400

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		6,83
6,86
-0.38%		10,0
5,02
99.28%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		-30,9
-30,7
-0.59%
-38,7

EBIT
Million USD		Released
Forecast
Spread 		-16,8
-17,2
2.18%		-14,2
-19,2
26.36%		-27,8
-27,4
-1.42%		-28,2
-28,9
2.15%		-31,1
-30,9
-0.82%
-34,9

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.88%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-29,9
-0.47%
-34,4

Net income
Million USD		Released
Forecast
Spread 		-18,6
-18,9
1.85%		-15,7
-20,9
24.86%		-27,8
-26,9
-3.43%		-28,3
-29,1
2.67%		-30,0
-30,0
-0.13%
-33,7

EPS
USD		Released
Forecast
Spread 		-10,8
-11,0
1.82%		-4,50
-6,60
31.82%		-3,20
-3,27
2.04%		-1,86
-1,83
-1.82%		-1,58
-1,59
0.32%
-0,51

Announcement Date12/03/2009/03/2110/03/2223/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-6,96
-6,57
-5.9%		-6,57
-7,21
8.84%		-7,18
-7,05
-1.77%		-7,56
-7,35
-2.9%		-6,93
-7,66
9.5%		-7,37
-7,08
-4.16%		-7,32
-7,51
2.55%		-8,13
-7,51
-8.19%		-8,30
-8,05
-3.11%
-8,70


-8,70


-9,55


-9,55




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,13
-6,14
-16.24%		-6,72
-7,20
6.75%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.41%		-7,82
-7,31
-6.99%		-8,06
-7,91
-1.94%
-8,56


-8,46


-9,33


-9,39




Net income
Million USD		Released
Forecast
Spread 		-7,13
-6,14
-16.24%		-6,72
-7,20
6.73%		-7,26
-7,14
-1.67%		-7,55
-7,39
-2.13%		-6,80
-7,70
11.75%		-7,14
-6,99
-2.1%		-7,01
-7,34
4.39%		-7,82
-7,31
-6.99%		-8,06
-8,01
-0.7%
-8,07


-8,11


-8,92


-9,22




EPS
USD		Released
Forecast
Spread 		-0,70
-0,67
-5%		-0,50
-0,53
6.25%		-0,50
-0,49
-3.09%		-0,50
-0,49
-2.04%		-0,40
-0,51
21.57%		-0,42
-0,44
3.82%		-0,37
-0,41
9.76%		-0,40
-0,40
-0.84%		-0,40
-0,40
-1.27%
-0,22


-0,11


-0,12


-0,12


-0,14

Announcement Date10/03/2212/05/2211/08/2210/11/2223/03/2311/05/2308/08/2309/11/2321/03/24-----

Upcoming sector events for Regulus Therapeutics Inc.

Today 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
More events

Past sector events for Regulus Therapeutics Inc.

Today JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
Today BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)
Today PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
Today HITGEN INC.: Q4 2023 Earnings Release
2024-04-24 04:05 pm VIKING THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-23 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SINOCELLTECH GROUP LIMITED: Q1 2024 Earnings Release (Projected)
2024-04-23 SHANGHAI MEDICILON INC.: Q4 2023 Earnings Release
2024-04-23 07:30 am KINIKSA PHARMACEUTICALS, LTD.: Q1 2024 Earnings Release
2024-04-17 BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Calendar Regulus Therapeutics Inc.